We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALZN icon
3001
Alzamend Neuro
ALZN
$4.98M
$313K ﹤0.01%
+121
New +$374K
CCLD icon
3002
CareCloud
CCLD
$100M
$313K ﹤0.01%
49,587
-3,177
-6% -$22.5K
EXAS
3003
DELISTED
Exact Sciences
EXAS
$312K ﹤0.01%
4,007
-114,413
-97% -$10.1M
FET icon
3004
Forum Energy Technologies
FET
$593M
$312K ﹤0.01%
19,471
-5,521
-22% -$110K
PRTS icon
3005
CarParts.com
PRTS
$42.4M
$312K ﹤0.01%
+2,782
New +$383K
TRN icon
3006
Trinity Industries
TRN
$3.03B
$311K ﹤0.01%
+10,304
New +$294K
BRMK.WS
3007
CALL
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$311K ﹤0.01%
+33,146
New +$3.46K
FCEL icon
3008
FuelCell Energy
FCEL
$1.57B
$310K ﹤0.01%
1,989
+39
+2% +$9.19K
CARM
3009
DELISTED
Carisma Therapeutics
CARM
$308K ﹤0.01%
18,997
+15,076
+384% +$303K
BWB icon
3010
Bridgewater Bancshares
BWB
$585M
$307K ﹤0.01%
+17,325
New +$310K
GS icon
3011
PUT
Goldman Sachs
GS
$305B
$307K ﹤0.01%
800
-27,700
-97% -$11M
AMG icon
3012
Affiliated Managers Group
AMG
$9.78B
$306K ﹤0.01%
1,852
-4,582
-71% -$768K
FFTY icon
3013
CapForce IBD 50 ETF
FFTY
$80.2M
$305K ﹤0.01%
+6,642
New +$317K
VNT icon
3014
Vontier
VNT
$4.62B
$305K ﹤0.01%
+9,946
New +$324K
CTVA icon
3015
Corteva
CTVA
$59.5B
$304K ﹤0.01%
6,432
-205,903
-97% -$9.38M
OPY icon
3016
Oppenheimer Holdings
OPY
$1.2B
$303K ﹤0.01%
+6,541
New +$322K
VRTV
3017
DELISTED
VERITIV CORPORATION
VRTV
$302K ﹤0.01%
+2,464
New +$297K
TGH
3018
DELISTED
Textainer Group Holdings limited
TGH
$300K ﹤0.01%
8,394
-90,869
-92% -$3.29M
CCAP icon
3019
Crescent Capital BDC
CCAP
$412M
$299K ﹤0.01%
+16,982
New +$326K
KWR icon
3020
Quaker Houghton
KWR
$2.67B
$299K ﹤0.01%
1,295
-16,129
-93% -$3.91M
VHT icon
3021
Vanguard Health Care ETF
VHT
$18.6B
$299K ﹤0.01%
1,119
-257
-19% -$65.5K
GAP
3022
The Gap Inc
GAP
$7.28B
$296K ﹤0.01%
16,744
-387,750
-96% -$8.12M
ITI
3023
DELISTED
Iteris, Inc.
ITI
$296K ﹤0.01%
+74,154
New +$359K
HOFT icon
3024
Hooker Furnishings Corp
HOFT
$150M
$295K ﹤0.01%
12,655
+4,451
+54% +$112K
MNOV icon
3025
MediciNova
MNOV
$65.5M
$295K ﹤0.01%
110,200
-174,502
-61% -$583K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.